Dubai, Vereinigte Arabische Emirate
€4,265,520 - €8,531,040
Data Analytics and Business Intelligence Expert, Artificial General Intelligence and Crypto asset Anti-Money laundering. Decentralised finance. ACAMS Certified.
Blockchain, Crypto Assets, DeFi, Anti-Money Laundering, AI
Oncology therapeutics redefined Onconetix, Inc. (Nasdaq: ONCO) (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. For more information, visit www.onconetix.com.
Innovating Healthcare and Life Sciences from Every Angle Throughout healthcare, providers, payers, and biopharma professionals are working hard to improve the system and deliver the best outcomes for patients and consumers. True change agents know it can’t be done alone. We strive to partner with you to reinforce your progress with our breakthrough technology and healthcare know-how. Together we’ll create an unshakeable system where you are empowered to do the work needed to transform healthcare.
Finanzen
Software
Technologie
Landwirtschaft
Unternehmensdienstleistungen
Ausbildung und Training
Energie und natürliche Ressourcen
Unterhaltung und Freizeit
Mode und Schönheit
Lebensmittel und Getränke
Restaurants und Bars
Herstellung und Engineering
Medien
Medizin und Pharma
Persönliche Dienstleistungen
Produkte und Erfindungen
Immobilie
Einzelhandel
Vertrieb und Marketing
Transport
AIN hilft Investoren und Unternehmern, dauerhafte und profitable Beziehungen aufzubauen, um bessere Geschäfte und eine bessere Zukunft zu schaffen.